Lv1
58 积分 2022-11-29 加入
Efficacy of liver transplantation after response to atezolizumab-bevacizumab downstaging of intermediate and advanced hepatocellular carcinoma (ImmunoXXL)
2小时前
已完结
ALPPS VS PVE VS LVD: selecting the optimal liver hypertrophy method for patients with liver malignancies, before undergoing large scale hepatectomy; A systematic review and meta-analysis
2小时前
求助中
ALPPS VS PVE VS LVD: selecting the optimal liver hypertrophy method for patients with liver malignancies, before undergoing large scale hepatectomy; A systematic review and meta-analysis
1个月前
已关闭
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
3个月前
已完结
Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma
3个月前
已完结
Hepatic Arterial Infusion Pump Chemotherapy in Patients With Unresectable Intrahepatic Cholangiocarcinoma—PUMP-2 Trial
5个月前
已完结
Molecular Testing and Targeted Therapies in Hepatobiliary Cancers
5个月前
已完结
Sorafenib plus Doxorubicin versus Sorafenib alone for advanced hepatocellular carcinoma (Soradox trial): final results of a prospective, randomized, open-label, multicenter phase IIB trial
8个月前
已完结
Outcome and management of patients with hepatocellular carcinoma who achieved a complete response to immunotherapy-based systemic therapy
8个月前
已完结
Conversion therapy of tislelizumab plus lenvatinib and GEMOX in unresectable locally advanced biliary tract cancer (ZSAB-TransGOLP): a multicentre, prospective, phase 2 study
9个月前
已完结
皖公网安备34019202002308
